Iron, Cobalt, Nickel, Vanadium, Molybdenum, Or Palladium Patents (Class 424/646)
-
Patent number: 8287848Abstract: A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations.Type: GrantFiled: September 27, 2007Date of Patent: October 16, 2012Assignee: Tris Pharma IncInventors: Ketan Mehta, Yu-Hsing Tu, Mahendra Shah
-
Publication number: 20120258152Abstract: Cosmetic preparations and formulations are described, comprising high concentration (from at least 75% to at least 95%) of thermal mineral waters within the aqueous portion of the formulation. In preferred embodiments, the thermal mineral waters are rendered more bioavailable by pre-fermentation with a microorganism such as the yeast Saccharomyces cerevisiae. Formulations are also described in which at least a portion of the thermal mineral water is incorporated into phospholipid liposomes.Type: ApplicationFiled: September 30, 2010Publication date: October 11, 2012Inventors: Stephen De Heinrich, Colette Margeurite Louise Haydon
-
Publication number: 20120251629Abstract: The present invention relates to a method of treating a patient for a condition where blood flow to a tissue or organ is interrupted. This method involves administering to a patient with a hypoxic condition where blood flow to a tissue or organ is interrupted, or at risk thereof, a compound that reduces the rate of HIF-1? inactivation in cells affected by the condition, thereby treating the patient for the condition. Also disclosed is a method of treating a tumor in a patient. In addition, the present invention relates to methods of identifying compounds as candidate drugs for treatment of hypoxic conditions and for treating tumors in a subject.Type: ApplicationFiled: October 8, 2010Publication date: October 4, 2012Applicant: UNIVERSITY OF ROCHESTERInventor: Marc Halterman
-
Publication number: 20120251450Abstract: Of the many compositions and methods provided herein, one composition includes a nanoparticle having a first oxide of a first metal and a dopant that includes an ion or an atom of a second metal. A method includes a method comprising providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; providing a diseased cell and a healthy cell; contacting the diseased cell and the healthy cell with the nanoparticle; and allowing the nanoparticle to preferentially associate with the diseased cell.Type: ApplicationFiled: April 4, 2011Publication date: October 4, 2012Inventors: Alex Punnoose, Denise Wingett
-
Publication number: 20120244224Abstract: A method of inducing mineralization in a bone cell is described. The method comprises contacting a bone cell with a composition comprising nanoparticles. The nanoparticles can be single-walled carbon nanotubes, hydroxyapatite nanoparticles, TiO2 nanoparticles or silver nanoparticles. The bone cell can be an osteoblast cell. A method for increasing bone mass, bone healing or bone formation is also described which comprises administering to a subject in need thereof an effective amount of a composition comprising nanoparticles. The subject can suffer from a bone disease such as osteoporosis. The subject can suffer from a bone fracture and the method can comprise contacting bone cells near the bone fracture site with the composition. The composition can further comprise a pharmaceutically acceptable carrier.Type: ApplicationFiled: March 21, 2012Publication date: September 27, 2012Applicant: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSASInventors: Alexandru S. BIRIS, Daniel CASCIANO, Meena Waleed MAHMOOD
-
Publication number: 20120225018Abstract: The present invention relates to compositions including a homeopathic aqueous substance active (HASA) and at least one hydrophilic gelling agent, the HASA comprises a homeopathic compound at a potency of 30 C or higher and an uninhibited aqueous composition. The present invention also relates to methods of preparing a hydrophilic HASA-gel matrix. The method includes combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; combining the HASA with at least one hydrophilic gelling agent; and thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.Type: ApplicationFiled: March 2, 2012Publication date: September 6, 2012Inventor: Nancy Josephine Polich
-
Publication number: 20120219639Abstract: A nutritional supplement for patients having cardiovascular disease including heat failure. The nutritional supplement comprises vitamin C, vitamin D, vitamin B1, vitamin B2, vitamin B6, and folic acid, wherein the supplement is further characterized in that it does not contain vitamin A, vitamin K, or copper. In some embodiments, the supplement also contains omega fatty acids.Type: ApplicationFiled: May 10, 2012Publication date: August 30, 2012Applicant: Nephroceuticals, LLCInventor: John Wigneswaran
-
Publication number: 20120213862Abstract: Negative ion-releasing silica compositions and methods for their preparation and use are described herein. The compositions include silicon dioxide and gadolinium. Further described herein are products including the compositions.Type: ApplicationFiled: May 6, 2011Publication date: August 23, 2012Applicant: ENERGY BALANCE GEAR LLCInventor: John Clark Walton
-
Publication number: 20120213866Abstract: A method for establishing a treatment for promoting the formation of substances in an individual. The measured or assessed level of substances in the body are compared in order to determine the treatment to provide to an individual.Type: ApplicationFiled: February 23, 2012Publication date: August 23, 2012Inventor: WILLIAM J. McFAUL
-
Publication number: 20120207802Abstract: Provided is a pigment composition comprising a first and second effect pigments, wherein the composition has a hue comparable to carmine but does not comprise carmine.Type: ApplicationFiled: February 14, 2012Publication date: August 16, 2012Inventor: Sung Yeun CHOI
-
Publication number: 20120207809Abstract: Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.Type: ApplicationFiled: November 30, 2011Publication date: August 16, 2012Inventor: Kambiz Thomas Moazed
-
Publication number: 20120207854Abstract: Aqueous solution, cream, hydrogel or spray composition containing compound Sn-On-Xn; where S(n=5-8), O (n=3-7) and X?Fe, Cr or Ni, and most effectively, S7-O4-Fe4 as active ingredient for cutaneous, intradermal and subcutaneous treatment of dermo-epithelial lesions, comprising but not limited to, certain types of skin cancer (basal cell, keratocanthoma and spinocellular carcinomas), conjunctivitis, folliculitis, acne, gingivitis, stomatitis, fungal, dermatomycosis, parasitosis, condylomatosis, balanitis, vaginitis, vaginosis, bacteriosis and endometriosis; by reducing the number of infecting microorganism, not limited to Candida sp., Actinobacillus actinomycetemcomitans, Pseudomonas sp., Porphyromonas gingivalis., Escherichia, sp., Staphyloccocus sp. Streptococcus sp., Herpes simplex I, Herpes simplex II, Coxackievirus A and B, Echovirus, Varicella Zoster (HHV-3), Human Papilloma Virus Gardnerella Vaginalis, Trichomonas vaginalis, Corynebacterium sp., present on the body skin and mucosas.Type: ApplicationFiled: February 11, 2011Publication date: August 16, 2012Inventors: Ricardo Carrizo-Manzanero, Rodolfo Salas-Auvert, Humberto Herrera-Merchan
-
Publication number: 20120203147Abstract: A method for increasing blood flow to vital organs during cardiopulmonary resuscitation of a person experiencing a cardiac arrest may include performing standard or active compression decompression cardiopulmonary resuscitation on a person to create artificial circulation by repetitively compressing the person's chest such that the person's chest is subject to a compression phase and a relaxation or decompression phase. The method may also include administering one or more vasodilator drugs to the person to improve the artificial circulation created by the cardiopulmonary resuscitation. The method may also include binding at least a portion of the person's abdomen, either manually or with an abdominal compression device. Performing cardiopulmonary resuscitation on a person may include ventilating the person with either an impedance threshold device or a intrathoracic pressure regulator.Type: ApplicationFiled: July 1, 2011Publication date: August 9, 2012Applicant: ResQSystems, Inc.Inventors: Keith Lurie, Demetris Yannopoulos
-
Publication number: 20120201861Abstract: In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=logC?logA], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 1× for 24 hours.Type: ApplicationFiled: February 9, 2012Publication date: August 9, 2012Inventors: Kayo NAKANO, Akira Sato, Takao Kusaka, Shinya Kasamatsu, Akito Sasaki, Daisuke Fukushi
-
Patent number: 8236284Abstract: Disclosed are nanoparticles having a metallic core consisting essentially of superparamagnetic iron oxide; a polymeric coat surrounding said core, the coat having a matrix of polyacrylic acid and forming an outer periphery of said nanoparticle; a plurality of hydrophobic pockets formed by the polymeric coat; a plurality of carboxylic groups along an outer periphery of the polymeric coat and effective to conjugate with a predetermined targeting ligand which functionalizes the nanoparticle; a lipophylic fluorescent dye encapsulated in the plurality of hydrophobic pockets; and a drug encapsulated in the plurality of hydrophobic pockets. Associated methods of making the nanoparticles and of treatments using the nanoparticles are also disclosed.Type: GrantFiled: April 2, 2009Date of Patent: August 7, 2012Assignee: University of Central Florida Research Foundation, Inc.Inventors: J. Manuel Perez, Santimukul Santra
-
Publication number: 20120195976Abstract: The present invention relates to the treatment of disorders using heme oxygenase-1 and heme degradation products.Type: ApplicationFiled: December 9, 2011Publication date: August 2, 2012Inventors: Fritz H. Bach, Pascal O. Berberat, Simon C. Robson
-
Publication number: 20120189692Abstract: The present invention generally relates to orally administered pharmaceutical compositions of iron compounds with medium chain fatty acid salts. The invention further relates to methods of using the pharmaceutical compositions to treat iron deficiency and related disorders.Type: ApplicationFiled: January 6, 2012Publication date: July 26, 2012Inventors: Alan Cullen, Edel O'Toole, David C. Coughlan, Kishore Chalasani, Thomas W. Leonard
-
Publication number: 20120189709Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.Type: ApplicationFiled: January 11, 2012Publication date: July 26, 2012Applicant: ABBOTT LABORATORIESInventors: Debra L. Thomas, Pradip Mukerji
-
Patent number: 8221536Abstract: A cosmetic containing a pearlescent pigment comprising a substrate and a first layer, wherein the first layer comprises iron oxide, wherein the iron has from about 1% to about 30% Fe(II) and from about 70% to about 99% Fe(III).Type: GrantFiled: October 31, 2007Date of Patent: July 17, 2012Assignee: Sun Chemical Corp.Inventors: Aaron M. Hollman, Stephane Nicolas, Philippe Schottland, Marguerite Debacker, Aurelie Antonowicz, Hai Hui Lin
-
Publication number: 20120177744Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.Type: ApplicationFiled: January 11, 2012Publication date: July 12, 2012Applicant: ABBOTT LABORATORIESInventors: Debra L. Thomas, Pradip Mukerji
-
Publication number: 20120171130Abstract: A composition is able to treat plant and animal diseases and includes a therapeutically effective amount of an encapsulated ionic mineral complex and a pharmaceutically acceptable carrier. The composition may also include other inert ingredients, botanical extracts and vitamin and mineral supplements.Type: ApplicationFiled: October 31, 2007Publication date: July 5, 2012Inventor: John Wayne Kennedy
-
Publication number: 20120171276Abstract: A virus inactivating sheet is provided that can inactivate viruses adhering thereto even in the presence of lipids and proteins regardless of whether or not the viruses have an envelope. The virus inactivating sheet can inactivate viruses adhering thereto and includes a sheet body, and monovalent copper compound fine particles and/or iodide fine particles that are held by the sheet body. The virus inactivating sheet can inactivate various viruses. These viruses can be inactivated even in the presence of lipids and proteins.Type: ApplicationFiled: October 4, 2010Publication date: July 5, 2012Inventors: Yoshie Fujimori, Youhei Jikihara, Tetsuya Sato, Yoko Fukui, Tsuruo Nakayama
-
Publication number: 20120171164Abstract: The present disclosure relates to the use of nutritional compositions including lactoferrin in supporting resistance to a viral respiratory tract infection. The method includes administering to a human a nutritional composition comprising a fat or lipid source, a protein source and lactoferrin produced by a non-human source.Type: ApplicationFiled: December 29, 2010Publication date: July 5, 2012Inventors: Anja Wittke, Dattatreya Banavara, Cecilia Munoz
-
Publication number: 20120156145Abstract: Compositions containing metal ions bound into a titanate are described which have demonstrated an ability to suppress bacterial growth of a number of organisms associated with periodontal disease and caries.Type: ApplicationFiled: July 14, 2011Publication date: June 21, 2012Inventors: David T. Hobbs, Mark C. Elvington, John Wataha, Whasun O. Chung, R. Bruce Rutherford, Daniel C. Chan
-
Patent number: 8202546Abstract: In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 300 mg of vitamin C; about 1200 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folate; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 300 mcg of biotin; about 50 mg of calcium; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 25 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 2 mg of lutein; about 500 mcg of lycopene; about 5 mg of pepper extract; and at least one or more excipients.Type: GrantFiled: February 2, 2010Date of Patent: June 19, 2012Assignee: Vertical Pharmaceuticals, Inc.Inventors: Steven A. Squashic, Kevin M. Hudy, David C. Purdy
-
Publication number: 20120148648Abstract: A composition comprising a pigment particle that is coated with a cationic material and isopropyl titanium triisostearate. The pigment particle can be included in a cleansing composition for deposition on a surface, such as skin.Type: ApplicationFiled: August 31, 2009Publication date: June 14, 2012Applicants: Kobo Products Inc., Cologate-Palmolive CompanyInventors: Yun Shao, David Schlossman, Neringa Kontrimiene, Ariel Haskel
-
Publication number: 20120148633Abstract: The present invention relates to galvanic particulates, their methods of manufacture and uses in treatments are described. The galvanic particulates may be binary or tertiary galvanic particulates, for example, containing multiple layers or phases of conductive materials.Type: ApplicationFiled: March 25, 2010Publication date: June 14, 2012Inventors: Ying Sun, Jue-Chen Liu, Michael Southall, Luiz Arthur Bonaci Tessarotto, Leon B. Kriksunov
-
Patent number: 8197855Abstract: The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.Type: GrantFiled: October 30, 2007Date of Patent: June 12, 2012Assignee: Everett Laboratories, Inc.Inventors: John A. Giordano, Charles J. Balzer
-
Patent number: 8197854Abstract: A nutritional supplement for use in physiologically stressful conditions is disclosed. The nutritional supplement may include one or more of vitamin A, vitamin E, vitamin D3, vitamin C, vitamin B1, riboflavin, niacin, folic acid, vitamin B6, biotin, pantothenic acid, vitamin B12, magnesium, zinc, selenium, chromium, copper, iron, alpha lipoic acid, lutein and lycopene.Type: GrantFiled: March 7, 2011Date of Patent: June 12, 2012Assignee: Vertical Pharmaceuticals, Inc.Inventors: Steven A. Squashic, Kevin M Hudy, David C. Purdy
-
Publication number: 20120141448Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.Type: ApplicationFiled: November 23, 2011Publication date: June 7, 2012Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jäger
-
Publication number: 20120128748Abstract: Organic-inorganic composite particles includes inorganic oxide particles each of which has a cationic charge on the particle surface and polymer gel molecules which are derived from a natural substance, have an anionic functional group and one or more hydroxyl groups in a molecule and have both a shrinking and a swelling property, the polymer gel molecules are electrostatically bonded to surfaces of the inorganic oxide particles; a process for producing the particles; a dispersion containing the particles; and a cosmetic containing the particles. These organic-inorganic composite particles have good dispersibility not only in aqueous solvents such as water but also in non-aqueous solvents and further have characteristics that aggregation of the particles scarcely occurs.Type: ApplicationFiled: July 30, 2010Publication date: May 24, 2012Applicant: JGC CATALYSTS AND CHEMICALS LTD.Inventors: Kensuke Nagata, Michio Komatsu
-
Patent number: 8182800Abstract: This invention relates to high surface area materials, such as nanoparticles, that are coated with metal ions. These modified nanoparticles have active sites that bind various gases and/or odorous compounds, thereby removing these compounds from a medium such as air or water. Metal ions are adsorbed onto the surface of the nanoparticle and bound strongly to the surface. By selection of the metal ion, specific gaseous compounds and/or odorous compounds can be targeted and removed efficiently and effectively from both aqueous phase and from the air. The modified nanoparticles are useful in numerous article of manufacture for industrial and consumer use.Type: GrantFiled: August 25, 2009Date of Patent: May 22, 2012Assignee: Kimberly-Clark Worldwide, Inc.Inventor: John Gavin MacDonald
-
Publication number: 20120121727Abstract: The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.Type: ApplicationFiled: January 23, 2012Publication date: May 17, 2012Applicant: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Kai THEDE, Ingo FLAMME, Felix OEHME, Jens-Kerim ERGÜDEN, Friederike STOLL, Joachim SCHUHMACHER, Hanno WILD, Peter KOLKHOF, Hartmut BECK, Jörg KELDENICH, Metin AKBABA, Mario JESKE
-
Patent number: 8178081Abstract: A method for reducing odor is provided. The method comprises forming a coordination complex between a transition metal and a polydentate compound, and contacting the coordinated complex with an odorous compound. The transition metal provides one or more active sites for capturing the odorous compound. In some embodiments, the polydentate compound may be a polyalkylimine, such as polyethyleneimine, polypropyleneimine, or a dendrimer thereof.Type: GrantFiled: July 13, 2010Date of Patent: May 15, 2012Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Bin Wu, Kevin P. McGrath, Jaeho Kim, Bao Trong Do, Sharon Linda Greene, Yanbin Huang, Kaiyuan Yang
-
Publication number: 20120114743Abstract: Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.Type: ApplicationFiled: January 17, 2012Publication date: May 10, 2012Inventor: Keith Delprete
-
Publication number: 20120114758Abstract: The invention generally relates to nutrient enhanced beverages which include certain levels of the most current Daily Recommended Intakes of macronutrients and Micronutrients, and the rationale for increased allowances during pregnancy. The beverages of the invention generally comprise one or more macronutrients, vitamins and minerals recommended for consumption by pregnant or lactating women in an amount that is effective for enhancing the nutrition of pregnant and lactating women, and that is not harmful to developing fetuses or breast-feeding babies. In particular, the invention provides high doses of more easily absorbable iron to increase bioavailability of both iron and calcium which normally are not ingested in the needed doses, or are usually ingested via hard to swallow and digest prenatal, iron and calcium pills that can cause stomach cramps, diarrhea, constipation and other gastro-intestinal effects, that often lead to women not getting enough necessary nutrients.Type: ApplicationFiled: April 27, 2011Publication date: May 10, 2012Inventor: James Elgin Rea
-
Patent number: 8173154Abstract: A method and compositions for wound care management comprising a dressing comprising a three-dimensional body of glass-based fibers comprising 40 to 80 weight % B2O3, wherein at least 25 wt. % of the fibers have a diameter between 200 nm and 4000 nm, and a length:width aspect ratio of at least 10. The glasses may also be used for wound care as fibers formed into sutures, as particles in surgical glue to close a wound, or as particles in an ointment or cream to apply to a wound. The compositions may comprise glass formers P2O5 and/or SiO2; alkali oxides selected from Li2O, Na2O, K2O, and Rb2O; and/or alkaline earth oxides selected from MgO, SrO, BaO and CaO. The compositions may further comprise 0.05 to 10 wt. % of one or more trace elements selected from Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn.Type: GrantFiled: January 6, 2010Date of Patent: May 8, 2012Assignee: The Curators of the University of MissouriInventors: Steven B. Jung, Delbert E. Day
-
Publication number: 20120107410Abstract: The present invention relates to a product obtained from gastropod spawn, to be used to prepare dermatological, cosmetic or cosmeceutical compositions designed for skin care; said product has the capacity to activate and mobilise skin stem cells, as well as prevent the loss thereof that takes place as a consequence of chronological and premature ageing. The present invention also relates to the process followed in order to obtain said product.Type: ApplicationFiled: January 28, 2010Publication date: May 3, 2012Applicant: Industrial Farmaceutica Cantabria, S.A.Inventors: Marta Dominguez Valdes-Hevia, Aurora Brieva Delgado, Salvador Gonzalez Rodriguez, Eduardo Reyes Martin, Jose Carballeira Morado, Ernesto Quintana Gonzalez, Juan Pablo Pivel Ranieri, Antonio Guerrero Gomez-Pamo, Angeles Juarranz De La Fuente, Jesus Espada Regalado, Francisco Sanz Rodriguez
-
Patent number: 8168232Abstract: The present invention relates to methods and formulations for inhibiting, treating and preventing a malignant cell phenotype, cell, tumor and/or disease. Administration of nitric oxide mimetics, such as low doses, is sufficient to increase, restore or maintain nitric oxide-mediated signaling in cells so that malignant cell phenotypes, cells, tumors and/or diseases are inhibited or prevented. These methods and formulations are particularly useful in treating and preventing cancer in animals.Type: GrantFiled: February 25, 2010Date of Patent: May 1, 2012Assignee: Queen's University at KingstonInventors: Charles H. Graham, Lynne-Marie Postovit, Michael A. Adams, Jeremy P. W. Heaton
-
Publication number: 20120100119Abstract: Three types of trisiloxane surfactants having the basic formula: MDM? are described wherein the substituents on the differing M and M? groups, in conjunction with pendant polyalkylene oxide substituents on the D group render the surfactant resistant to hydrolysis under either basic or acidic conditions outside the pH range of 6.0 to 7.5. The compositions are useful in agricultural, household and cosmetic applications.Type: ApplicationFiled: December 8, 2011Publication date: April 26, 2012Applicant: Momentive Performance Materials Inc.Inventors: George A. Policello, Mark D. Leatherman, Wenqing Peng, Suresh K. Rajaraman, Sophia Xia
-
Publication number: 20120100223Abstract: Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area.Type: ApplicationFiled: December 20, 2011Publication date: April 26, 2012Applicant: ASHA NUTRITION SCIENCES, INC.Inventor: Urvashi BHAGAT
-
Patent number: 8163298Abstract: A personal care composition in the form of an aqueous gel may comprise an alpha-hydroxy acid, wherein the pH of the composition is less than about 4.5. The personal care composition comprises a gelling agent and an aqueous solvent. The personal care composition further comprises particulates and an effective amount of suspension agent to suspend the particulates. The personal care composition exhibits a consumer desired viscosity and translucency.Type: GrantFiled: October 28, 2009Date of Patent: April 24, 2012Assignee: The Procter & Gamble CompanyInventors: Susan Adair Griffiths-Brophy, Dennis Eugene Kuhlman
-
Publication number: 20120087877Abstract: The invention relates to a composition based on mineral concentrates and a method of preparing this composition. The composition comprises a powder or a mixture of powders containing at least one silicon derivative and at least one trace element other than silicon, as a mixture with a carrier and physiologically acceptable excipients. Application in cosmetology and dermatology for protecting the skin.Type: ApplicationFiled: October 14, 2011Publication date: April 12, 2012Applicant: BULGARI PARFUMSInventors: Jean-Claude ALLART, Jean-Marie Lefevre, Jacques Peyrot, Jean-Paul Marty
-
Patent number: 8153163Abstract: The present invention relates to a pearl pigment obtained by coating the surface of a flaky powder with a colored metal or a colored metal oxide and further coating the surface of the above colored metal- or colored metal oxide-coated flaky powder with a colorless metal or a colorless metal oxide, wherein when the pearl pigment is applied onto the surface of black artificial leather in an average amount of 0.05 mg/cm2 and the intensity of light reflected from the pearl pigment is measured using illuminant C at a 2° viewing angle with a spectrophotometric colorimeter which is provided with a sheet polarizer S on the light incident side and a sheet polarizer P on the light receiving side, the powder reflection light which is incident to the pearl pigment as a measurement sample at an angle of 45° to the direction normal to the surface of the sample and is received in the direction normal to the surface of the sample has absolute values a* and b* of 10 or less, and make-up cosmetics containing the pearl pigment.Type: GrantFiled: June 28, 2011Date of Patent: April 10, 2012Assignees: Kao Corporation, Nihon Koken Kogyo KKInventors: Eiichiro Misaki, Hiroyuki Shiomi, Maoya Adachi, Takahiro Kaida
-
Publication number: 20120070505Abstract: The invention relates to novel functional amphiphilic molecule or macromolecule formulations with multiple compartments for transporting or targeting at least one therapeutic agent, in particular an antitumor agent, as well as to a method for preparing such formulations and to the use thereof.Type: ApplicationFiled: May 28, 2010Publication date: March 22, 2012Applicants: UNIVERSITE DE LA MEDITERRANEE, UNIVERSITE BORDEAUX SEGALENInventors: Philippe Barthelemy, Salim Khiati, Michel Camplo
-
Publication number: 20120064127Abstract: It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a) a lipid fraction comprising at least one of docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c) a mineral fraction comprising at least one of manganese and molybdenum, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.Type: ApplicationFiled: November 11, 2011Publication date: March 15, 2012Applicant: N.V.NUTRICIAInventor: Robert J.J. Hageman
-
Patent number: 8133479Abstract: The object of the present invention is to provide a hair restorer which exhibits a stimulatory effect on hair restoration against hair loss, hair thinning, split ends, hair graying, etc., with higher stability and safety than those of known hair restorers containing 5-aminolevulinic acids as active components. By using 5-aminolevulinic acid or its salt or its derivative, and a composition containing iron sodium diethylenetriaminepentaacetate or iron ammonium diethylenetriaminepentaacetate as active components, a hair restorer and a method for restoring hair which are excellent in hair growth promotion, and stability and safety, are provided.Type: GrantFiled: July 6, 2004Date of Patent: March 13, 2012Assignee: Cosmo Oil Co., Ltd.Inventor: Yoshiyasu Ito
-
Publication number: 20120059307Abstract: Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.Type: ApplicationFiled: August 26, 2011Publication date: March 8, 2012Applicant: SIENNA LABS, INC.Inventors: Todd James Harris, Alice Ann Chen
-
Publication number: 20120052135Abstract: Subject of the present invention are compositions comprising a mixture of calcium, magnesium and iron salts for use as a pharmaceutical preparation for adsorbing phosphate, especially for use as pharmaceutical preparations for the treatment of hyperphosphataemia, chronic kidney deficiency as well as for the treatment of haemodialysis patients.Type: ApplicationFiled: March 1, 2010Publication date: March 1, 2012Applicant: VIFOR (INTERNATIONAL) AGInventors: Gisela Witzel, Peter O. Geisser, Erik Philipp
-
Publication number: 20120045518Abstract: Methods for controlling bleeding (e.g., enhancing coagulation and reducing fibrinolysis) in a subject are disclosed. The methods include selecting a subject in need of enhanced coagulation or reduced fibrinolysis, and administering to the subject a carbon monoxide releasing molecule (CORM). Examples of CORMs include tricarbonyldichloro-ruthenium (II) dimer, tricarbonylchloro-(glycinato)ruthenium (II), sodium boranocarbonate, dimanganese decacarbonyl, and iron pentacarbonyl. Further disclosed are compositions and methods for treating a subject in need of a blood product by administering to the subject a composition including a CORM and a blood product (e.g., cryoprecipitate or fresh frozen plasma).Type: ApplicationFiled: March 5, 2010Publication date: February 23, 2012Applicant: THE UAB RESEARCH FOUNDATIONInventors: Vance G. Nielsen, James F. George, James K. Kirklin